In the individual financial summary for the fiscal year ending December 2025, Shiseido recorded an equity method investment valuation loss of 180.3 billion yen as an extraordinary loss, with no impact on the consolidated financial results.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4911","jir_company_name":"Shiseido Company, Limited","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-02-10","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/02\/4911-20260210-03.pdf","jir_short_summary":"In the individual financial summary for the fiscal year ending December 2025, Shiseido recorded an equity method investment valuation loss of 180.3 billion yen as an extraordinary loss, with no impact on the consolidated financial results.","jir_summary":"### Regarding the Recording of Equity Method Investment Valuation Loss\nShiseido Company, Limited recognized a decline in the fair value of shares of Shiseido Americas Corp. in its individual financial statements for the fiscal year ending December 2025 and recorded an equity method investment valuation loss of 180.3 billion yen as an extraordinary loss based on the Japanese GAAP \"Accounting Standard for Financial Instruments.\" This relates to the revision of full-year earnings guidance and the announcement regarding goodwill impairment losses for the Americas business disclosed on November 10, 2025.\n\n### Impact on Consolidated Financial Results and Future Outlook\nThis equity method investment valuation loss is recorded only in the individual financial statements, and it is clearly stated that there will be no impact on consolidated full-year financial results or future outlook for 2025. Therefore, no changes are indicated in the performance evaluation on a consolidated basis.","jir_financial_highlights":"Equity Method Investment Valuation Loss: 180.3 billion yen (Unknown)\nImpact on Consolidated Financial Results: None (Unknown)","jir_category":"","jir_hashtags":"#Shiseido, #FinancialSummary, #EquityMethodInvestmentValuationLoss","jir_key_figures":"Equity Method Investment Valuation Loss: 180.3 billion yen (extraordinary loss recorded)\nImpact on Consolidated Financial Results: None\nAnnouncement Date: 2026-02-10","jir_meta_title":"Shiseido Records 180.3 Billion Yen Equity Method Investment Valuation Loss in Fiscal 2025 Individual Financial Summary with No Impact on Consolidated Results","jir_meta_description":"Shiseido Company, Limited recorded a 180.3 billion yen equity method investment valuation loss as an extraordinary loss in its fiscal 2025 individual financial summary. There is no impact on consolidated results or future outlook.","jir_og_title":"Shiseido Records 180.3 Billion Yen Equity Method Investment Valuation Loss in Fiscal 2025 Individual Financial Summary","jir_og_description":"Shiseido recorded an equity method investment valuation loss of 180.3 billion yen in its fiscal 2025 individual financial summary, but there is no impact on consolidated financial results.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":7604,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"financial_summary","footnotes":""},"sector":[],"importance":[],"class_list":["post-27073","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n